Variation polygenic scoring method for predicting phenotypic variability and quantifying genetic plasticity

Background

The fields of genetic epidemiology and social science utilize genomic data to understand how human traits interact with external factors. Researchers analyze genotypic information from SNP-chips or whole genome sequencing to study gene-environment interplay and predict phenotypic outcomes. There is a critical need to understand genetic plasticity—the degree to which an individual’s traits fluctuate in response to environmental changes, medical treatments, or external shocks. Identifying subjects who exhibit highly variable responses is essential for optimizing clinical trial designs, understanding heterogeneous treatment effects, and mapping how environmental shifts impact population health.

Current genetic scoring approaches are fundamentally limited because they are designed exclusively to predict the mean average level of a trait. Traditional polygenic scores aggregate genetic variants to estimate a static, expected outcome, entirely missing the dispersion or variability of that phenotype. Consequently, conventional methods cannot capture an individual’s underlying sensitivity to environmental influences. By focusing solely on mean effects, existing models fail to identify genetic moderation of environmental shocks. This blind spot prevents researchers from recognizing individuals who might experience extreme phenotypic fluctuations, ultimately obscuring the complex dynamics of gene-environment interactions and limiting targeted interventions.

Technology

The Variation Polygenic Index/Score (vPGS) is a computational solution that calculates a genetic score predicting the variability, or dispersion, of a phenotype. It processes genotypic data from SNP-chips or whole genome sequencing using statistical models to isolate variance effects. Phenotypic data is transformed via squared z-scores to emphasize deviations from the mean. Genotypes are then regressed against these measures utilizing mean-variance vQTL analyses—such as heteroskedastic linear mixed models—or sibling-based analyses that control for shared environments. These regression weights are aggregated to generate a single vPGS quantifying an individual’s genetic plasticity for gene-environment interaction analysis.

This technology is uniquely differentiated by shifting the analytical focus from average outcomes to individual variability. Traditional polygenic scores merely predict the mean level of a trait to estimate baseline characteristics. In contrast, the vPGS quantifies an individual’s genetic propensity for plasticity in response to external factors. By predicting the spread around the mean, this solution identifies subjects who exhibit highly variable responses to environmental changes, clinical treatments, or external shocks. This ability to measure variability moderation makes it an unprecedented tool for optimizing clinical trials, enhancing personalized risk profiling, and mapping complex gene-environment interactions.

Benefits

• Captures an individual’s genetic plasticity and propensity for phenotypic variability, offering insights beyond traditional polygenic scores that only predict average trait levels.
• Identifies individuals who are highly sensitive or exhibit statistically variable responses to environmental changes, external shocks, or policy interventions.
• Optimizes clinical trials by selecting subjects likely to have variable treatment responses, which increases statistical power and reduces overall trial costs.
• Enables highly accurate gene-environment (GxE) interaction studies by successfully isolating variance effects from mean effects using advanced statistical models like HLMM and sibling-based analyses.
• Offers broad applicability across medicine and social sciences, as the method can be adapted to analyze any measurable trait (such as BMI, height, or educational attainment) where genetic and phenotypic data are available.

Applications

• Clinical trial patient stratification
• Predicting drug response variability
• Personalized healthcare risk profiling
• Targeted population health interventions
• Precision lifestyle intervention planning

Additional info

This methodology calculates a Variation Polygenic Index/Score (vPGS) to predict phenotypic dispersion rather than mean averages. It processes genotypic data using Levene’s test or heteroskedastic linear mixed models to isolate variance effects. By regressing genotypes against transformed measures—like squared z-scores or sibling-based spread—it quantifies genetic plasticity. This metric identifies individuals with variable responses to environmental shifts or clinical treatments, facilitating precise gene-environment interaction analysis.